We have compared the effects of xenon and nitrous oxide on central nervous system (CNS) electrical activity during sevoflurane anaesthesia in cats by recording the electroencephalogram (EEG), multi-unit activity of the midbrain reticular formation (R-MUA) and somatosensory evoked potentials (SEP). Basal anaesthesia with 2% and 5% sevoflurane was used. With 2% sevoflurane, 70% xenon initially produced rhythmic slow waves which were followed by bursts of high-amplitude sharp waves interrupted by low amplitude slow waves on the EEG. Xenon induced an initial increase, followed by a decrease in R-MUA. Nitrous oxide 70% decreased the amplitude of the EEG activity which was associated with an increase in R-MUA. Xenon suppressed the amplitude of both the initial positive and negative deflections of the SEP to a greater extent than nitrous oxide. With 5% sevoflurane anaesthesia, both anaesthetics increased the frequency of spikes on the EEG and facilitated R-MUA. These findings indicate that xenon has a stimulatory action on CNS background activity and a suppressive action on CNS reactive capability which is more potent than that of nitrous oxide. (Br.
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We have compared the effects of xenon and nitrous oxide on central nervous system (CNS) electrical activity during sevoflurane anaesthesia in cats by recording the electroencephalogram (EEG), multi-unit activity of the midbrain reticular formation (R-MUA) and somatosensory evoked potentials (SEP). Basal anaesthesia with 2% and 5% sevoflurane was used. With 2% sevoflurane, 70% xenon initially produced rhythmic slow waves which were followed by bursts of high-amplitude sharp waves interrupted by low amplitude slow waves on the EEG. Xenon induced an initial increase, followed by a decrease in R-MUA. Nitrous oxide 70% decreased the amplitude of the EEG activity which was associated with an increase in R-MUA. Xenon suppressed the amplitude of both the initial positive and negative deflections of the SEP to a greater extent than nitrous oxide. With 5% sevoflurane anaesthesia, both anaesthetics increased the frequency of spikes on the EEG and facilitated R-MUA. These findings indicate that xenon has a stimulatory action on CNS background activity and a suppressive action on CNS reactive capability which is more potent than that of nitrous oxide. (Br. J. Anaesth. 1998; 80: 628-633) Keywords : anaesthetics volatile sevoflurane; anaesthetics gases xenon; anaesthetics gases nitrous oxide; monitoring electroencephalography; monitoring evoked potentials; cat Xenon is an inert gas that has anaesthetic properties. 1 Its minimum anaesthetic alveolar concentration (MAC) is approximately 71% in humans, 2 that is, more potent than nitrous oxide. Induction of and emergence from xenon anaesthesia are rapid because of its low blood-gas partition coefficient (0.14). 3 It is non-explosive, non-toxic, unreactive and does not undergo biotransformation. Despite such advantages, until now it has not been used in clinical practice because of its expense. However, a decrease in its cost and the availability of a closed anaesthetic breathing system have recently rekindled interest in xenon. 4 Xenon may be used as an alternative to nitrous oxide. In addition to the anaesthetic actions of nitrous oxide, a stimulatory action on the central nervous system (CNS) has been identified. [5] [6] [7] In this study, we compared the actions of xenon on the CNS with those of nitrous oxide by monitoring the electroencephalogram (EEG), reticular multi-unit activity (R-MUA) and somatosensory evoked potentials (SEP).
Materials and methods
We studied nine cats of both sexes, weighing 2.1-4.5 kg, after obtaining approval from our Institutional Committee on Animal Research.
PLACEMENT OF ELECTRODES
The animals were anaesthetized with 5% sevoflurane in oxygen in a small anaesthesia box (40 40 35 cm). A hind limb vein was cannulated and pentobarbital 5-10 mg kg 91 was injected i.v. Sevoflurane was then discontinued and the surgical procedures were performed under i.v. pentobarbital anaesthesia (total dose of pentobarbital used was 40 mg kg
91
). The animals were placed on a stereotaxic apparatus, and electrodes were implanted over the frontal sinus, parietal cortex, occipital cortex, amygdala (A:12, L:11, D:-6), dorsal hippocampus (A:2, L:9, D:9) and midbrain reticular formation (A:2, L:<3, D:92), according to the atlas of Snider and Niemer. 8 The parietal cortex electrode in the right side was placed over the sensorimotor cortex (posterior sigmoid gyrus) for recording of SEP. For the cortical surface electrodes, we drilled the bone so as to reach, but not penetrate, the dura. For the depth electrodes, we made the same hole and punctured the dura using an 18-gauge needle. The cortical electrodes were made of stainless steel screws, 2 mm in diameter. The subcortical electrodes were made of side-by-side stainless steel wires, 0.2 mm in diameter, insulated with epoxyresin, except for the cut-end tips. The distance between the tips was 0.5-1.0 mm. Electrode position in the limbic structures was determined by monitoring EEG activity: the electrodes were advanced in 1-mm steps until seizure activity appeared on the EEG. 9 Such seizure activity is induced by injury and is typical of the limbic structures. All leads were connected to a miniature vacuum tube socket, which was fixed to the skull with dental cement. After implantation of the electrodes, the animals were kept in an observation box. On the following day they were moved to a temperature-controlled (23 ЊC) environment, on a 12-h light-dark cycle (lights on 08:00-20:00 h) and were fed food and water ad libitum.
RECORDING OF CNS ELECTRICAL ACTIVITY
For cortical EEG recording, the frontal sinus electrode was used as a reference. Depth EEG was recorded using bipolar electrodes. The time constant was set at 0.1 s and the high-cut filter at 100 Hz. R-MUA was obtained differentially between the two active points of the electrodes, amplified (1205C, San-ei, Tokyo) and sent to a high frequency band-pass filter. The high-frequency activity was rectified and smoothed with an electric circuit (envelope detector), using a smoothing time constant of 50 ms. It was expressed as the oscillation of DC voltage: the higher the DC level, the greater the firing of a population of units. The noise level of the recording was estimated by the DC level obtained by inserting a 10-k⍀ resistor and a short across the input in place of the animal. 5 7 9 10 In conscious animals, the signal to noise ratio exceeded 10 in all cases. Amplified signals of the EEG and the DC voltage of the R-MUA were fed into a computer via an analogue-to-digital converter (Mac Lab/8s, AD Instruments, Castle Hill, Australia) and stored on hard disk.
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On the SEP recording, two dermal needles were placed 1 cm apart, subcutaneously, near the radial nerve of the forepaw that was contralateral to the SEP recording site. A single square wave pulse of 0.5 ms duration with supramaximal intensity required to produce maximal amplitude in the SEP (approximately 10 V) was delivered every 3 s by an electrical stimulator (3F46, NEC San-ei) via an isolator (5384, NEC San-ei). Electrical activity of the parietal cortex electrode was transferred through an AC amplifier (1253A, NEC San-ei, Tokyo) with the time constant set at 0.1 s and high cut-off filter to a computer (Macintosh LC575, Apple, Cupertino, CA, USA), using an analogue-to-digital converter (Mac Lab/8s, AD Instruments, Castle Hill, Australia). Evoked potentials were averaged by 10 trials using a computer program (Scope, AD instruments, Castle Hill, Australia) and stored on hard disk.
EXPERIMENTAL PROCEDURES
At least 4 weeks after implantation of electrodes, the effects of xenon or nitrous oxide on CNS electrical activity were studied. For EEG and R-MUA recordings, administration of xenon or nitrous oxide was performed on different days. For SEP recording, both agents were administered successively in a random sequence on the same day. An interval of at least 2 weeks between each experiment was used, that is between investigation of the effect of xenon administration of the EEG and R-MUA, effect of nitrous oxide administration on the EEG and R-MUA, and SEP recording during administration of both agents. The order of the experiments was always the EEG experiments first, followed by the SEP studies. In some cases the interval was more than 3 months. We were unable to maintain good recording conditions for the SEP experiment in three cats, and therefore we used three new cats for these studies.
For EEG and R-MUA recordings, the animals were first anaesthetized with 5% sevoflurane in oxygen in the anaesthesia box. A hind limb vein was cannulated for infusion of fluids and drugs. Vecuronium 4 mg was given i.v. and the trachea intubated. In the case of xenon administration, in order to reduce the consumption of xenon, it was administered by manual ventilation of the lungs, using a low-flow, semi-closed breathing system. Nitrous oxide was administered using a non-rebreathing animal ventilator (SN-480-5, Shinano, Tokyo). Concentrations of oxygen, nitrous oxide, carbon dioxide and sevoflurane were monitored continuously, with the gas sample obtained at the proximal end of the tracheal tube, using an anaesthetic gas monitor (Type 1304, Brüel and Kjaer, Naerum, Denmark). End-tidal carbon dioxide partial pressure was maintained at approximately 4.0 kPa. 13 In some animals, xenon concentration was monitored continuously using a xenon gas monitor (Anzai Sogyo, Tokyo). Body temperature was maintained at approximately 38 ЊC using an automatically regulated heating lamp and pad (ATB-1100, Nihon Kohden, Tokyo). 13 The inspired sevoflurane concentration was initially set at 2% or 5% for at least 30 min, and then the EEG and R-MUA were recorded. Twenty minutes after the start of recording, the inspired gas was changed from oxygen to 70% xenon in oxygen or 70% nitrous oxide in oxygen, with the inspired sevoflurane concentration unchanged. Either xenon or nitrous oxide was administered for 2 h, and then replaced with the preceding gas mixture of oxygen and sevoflurane. CNS electrical activity was recorded for 20 min to confirm recovery. When both concentrations of sevoflurane were used as basal anaesthesia on the same animal on the same day, at least 1 h was allowed between each recording.
Recording of SEP was performed on different days. Basal anaesthesia with 2% sevoflurane was used. The SEP was recorded 20 min before; every 30 min during and 20 min after xenon or nitrous oxide administration. The anaesthetics were administered for 2 h, at random, to the same animal on the same day. The interval between xenon and nitrous oxide administration was at least 1 h.
DATA ANALYSIS
Values for R-MUA and SEP were analysed using a computer program (Scope or Chart, AD Instruments, Castle Hill, Australia). The R-MUA signal was measured every 5 min as the distance from the lower limit of the rectified trace to the 10-k resistor line. With regard to the SEP, the amplitude and peak latency periods of the initial positive (P1) and negative (N1) deflections were measured. For R-MUA, baseline values were determined for an average time of 20 min before administration of anaesthetic gas, and all data were expressed as mean (SEM) percentage of baseline values. The values obtained immediately before xenon or nitrous oxide administration served as controls. Statistical analysis was performed by analysis of variance (ANOVA) using Statview 4.11J. When appropriate, post hoc comparisons (Fisher's protected least significant difference test) were performed. P:0.05 was considered significant.
Results

EFFECTS ON THE EEG
The EEG after 2% sevoflurane anaesthesia consisted of high-amplitude slow waves in the cortex and amygdala, and delta waves of 2-2.5 Hz in the dorsal hippocampus, as reported previously ( fig. 1A,  control) . 9 Xenon 70% initially induced rhythmic theta and delta slow waves in the cortex, occasional spike activities in the amygdala and slow waves in the dorsal hippocampus, in all six animals ( fig. 1A, 30  min) . Of the six cats, four developed bursts of high-amplitude sharp waves of 1-3 Hz interrupted by low-amplitude slow waves, in all three recording sites, 30-60 min later ( fig. 1A, 90 min) . The pattern of bursts of high-amplitude sharp waves interrupted by low-amplitude slow waves was occasionally replaced by the preceding EEG pattern. In the remaining two animals, the initial EEG pattern persisted during the observation period of 2 h. With 5% sevoflurane, the EEG consisted of highamplitude spike activities and low-voltage slow waves in all three recording sites, as reported previously ( fig. 1B, control) . 9 Xenon 70% increased the frequency of high-amplitude spikes ( fig. 1B , xenon administration).
Nitrous oxide 70% induced a decrease in amplitude, with frequency unchanged, in the cortex and amygdala, and an increase in the frequency of the dorsal hippocampus EEG, during 2% sevoflurane anaesthesia ( fig. 2A , nitrous oxide administration). With 5% sevoflurane anaesthesia, nitrous oxide increased the frequency of high-amplitude spikes ( fig. 2B, nitrous oxide administration) . In four of six animals, nitrous oxide induced rhythmic sine curve waves of 10 Hz between the high-amplitude spikes ( fig. 2B , nitrous oxide administration), as reported previously.
EFFECTS ON R-MUA
The effects of 70% xenon on R-MUA during 2% sevoflurane anaesthesia were variable. Of the six cats, four showed an initial increase which then fluctuated. R-MUA changes correlated with cortical EEG changes: an increase in R-MUA was associated with cortical rhythmic theta and delta slow waves, and a decrease with bursts of high-amplitude sharp waves interrupted by low-amplitude slow waves. In the two other cats, R-MUA showed a sustained increase with the EEG showing cortical rhythmic slow waves. For the average value, R-MUA showed a tendency to increase initially followed by a decrease with xenon ( fig. 3A) . In contrast, a sustained increase was observed with 5% sevoflurane (figs 3B, 4A). In Figure 5 Typical recordings of the effects of administration of xenon (Xe) or nitrous oxide (N 2 O) on cortical somatosensory evoked potentials (SEP) in a cat anaesthetized with 2% sevoflurane. contrast, 70% nitrous oxide induced a sustained increase in R-MUA with both 2% and 5% sevoflurane anaesthesia (figs 3, 4B). There were no significant differences between xenon and nitrous oxide on R-MUA with 5% sevoflurane (fig. 3B ).
EFFECTS ON SEP
Xenon 70% produced a small decrease in P1 amplitude and a greater decrease in N1 amplitude. Xenon slightly prolonged the peak latent period of both deflections ( fig. 5, tables 1, 2) . Nitrous oxide 70% slightly depressed P1 amplitude, but N1 amplitude was unaffected. The latent periods of both deflections were not affected by nitrous oxide ( fig. 5, tables  1, 2 ). There was a significant difference between 70% xenon and 70% nitrous oxide for the effects on N1 amplitude (table 2) .
Discussion
We have demonstrated that during 5% sevoflurane anaesthesia, xenon and nitrous oxide had similar effects on the EEG and R-MUA, that is activation of CNS activity. However, during 2% sevoflurane anaesthesia, the CNS actions of xenon were variable and both CNS stimulation and depression were confirmed: initial stimulation followed by suppression was observed in four of six animals while sustained activation was observed in the remaining two animals. In contrast, nitrous oxide always stimulated the CNS. Furthermore, xenon suppressed SEP to a greater extent than nitrous oxide. As we used animals anaesthetized with sevoflurane, the pharmacological action of the anaesthetics studied were therefore confounded by the action of sevoflurane, a convulsive anaesthetic. The use of sevoflurane was essential for ethical reasons as nitrous oxide is a weak anaesthetic and could not be studied alone.
Morris, Knott and Pittinger first described the EEG changes during surgery using xenon anaesthesia in patients. They observed depression of alpha activity and a low-voltage fast wave pattern in the initial stage, followed by rhythmic slow waves. 14 Although the exact concentration of xenon was not documented, considering that the operation was performed with xenon alone, the concentration was probably greater than 70% Recently, the effects of low concentrations of xenon on the EEG in humans and baboons have been reported. [15] [16] [17] Hartmann and colleagues reported that 35% xenon induced theta and delta activities on the EEG. 15 16 In contrast, Sclabassi and colleagues showed that 25-35% xenon induced no EEG slowing. 17 Our study, using cats, confirmed previous studies of xenon-induced theta and delta rhythmic waves in the cortex in humans and baboons. 15 16 One of the authors (K. M.) has classified general anaesthetics into three types based on CNS electrical activity: depressant, excitant and epileptogenic anaesthetics. 18 The CNS excitant anaesthetics, such as nitrous oxide, ether, ketamine and cyclopropane, induce rhythmic theta and delta slow waves on the EEG associated with an increase in R-MUA. The excitatory action of nitrous oxide in our study confirmed these views and our previous studies. 5 7 19 Furthermore, surgical noxious stimulation and stimulation by i.v. administration of depolarizing neuromuscular blocking agents, which have potent CNS activating actions, also produced rhythmic theta and delta slow waves in human infants and children anaesthetized with halothane. 10 20 Surgical stimulation induced similar rhythmic slow waves in adult humans anaesthetized with halothane. 21 Recently it was reported that mental effort such as calculation induces rhythmic theta waves on the EEG and in magnet-encephalography. 22 Although experimental and clinical settings are very different, collectively these findings indicate that induction by xenon of rhythmic theta and delta slow waves on the EEG which were associated with an increase in R-MUA in this study, represent CNS stimulation, and that xenon should also be classified as a CNS excitant anaesthetic.
The actions of xenon were both stimulating and suppressive on the CNS with 2% sevoflurane anaesthesia. However, it stimulated the CNS when the animals were more deeply anaesthetized with 5% sevoflurane. Such dual effects were not observed with nitrous oxide. Both nitrous oxide and xenon suppressed SEP. However, greater suppression of SEP was confirmed with xenon than with nitrous oxide. The greater suppressive action of xenon on the SEP and suppression observed by xenon on the EEG and R-MUA in lightly anaesthetized animals indicate that xenon has greater CNS suppressive actions than nitrous oxide. Greater suppression of R-MUA with 5% sevoflurane anaesthesia was required to demonstrate constant enhancement by xenon. This may be explained if we postulate that CNS stimulation by xenon is weak, and becomes evident when the activity is deeply suppressed by sevoflurane. The relative resistance of CNS stimulation by nitrous oxide to the depressant action of sevoflurane may be similar to resistance of the CNS stimulating action of nitrous oxide to the suppressive action of enflurane. 7 The greater suppressive action of xenon compared with nitrous oxide agrees with a MAC study in humans: the MAC of xenon is 71%, 2 while that of nitrous oxide is 105%. 23 Similarly, the oil:gas partition coefficient of xenon (1.9) is greater than that of nitrous oxide (1.4). 24 Xenon 70% required a lower dose of fentanyl than 70% nitrous oxide to maintain an adequate depth of anaesthesia. 4 25 The greater suppressive action of xenon compared with nitrous oxide on CNS reactive capability suggests that xenon is more suitable for anaesthesia than nitrous oxide.
Nitrous oxide exerts its analgesic action not only via a direct action on the intraspinal nociceptive cells but also via an indirect action by activating the descending inhibitory system. 26 The stimulatory actions of xenon on R-MUA in our study suggest that activation of the descending inhibitory system may be involved in the suppressive action of xenon on spinal neurones. 11 In summary, xenon had a stimulatory action on CNS background activity and a suppressive action on CNS reactive capability. These neurophysiological properties of xenon are similar to those of nitrous oxide and suggest that xenon is an excitatory anaesthetic. The more potent suppressive action of xenon compared with nitrous oxide on CNS reactive capability suggests that xenon is a valuable alternative to nitrous oxide.
